<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>COVID-19 Facilitation measures- Relaxation in procedure for  clearance of Pharma items requiring NOC/Approval from ADC</title>
    <link>https://www.taxtmi.com/circulars?id=63879</link>
    <description>Importers may submit pharma import applications and documents by email with authorised contact details; the Assistant Drug Controller will review and issue NOC electronically. Temporary acceptance of signed letterhead for labeling/testing guarantees substitutes for notarised stamp paper. Online signed requests may be made for pending Direct Delivery shipments. Vaccines and certain critical IVDs sampled fully may be released after document and protocol review, bank risk certificate and prior track record subject to central regulator conditions. Testing waivers for medicines used by treating physicians for COVID-19 may be allowed based on previous testing history.</description>
    <language>en-us</language>
    <pubDate>Tue, 14 Apr 2020 00:00:00 +0530</pubDate>
    <lastBuildDate>Fri, 01 May 2020 10:47:00 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=611809" rel="self" type="application/rss+xml"/>
    <item>
      <title>COVID-19 Facilitation measures- Relaxation in procedure for  clearance of Pharma items requiring NOC/Approval from ADC</title>
      <link>https://www.taxtmi.com/circulars?id=63879</link>
      <description>Importers may submit pharma import applications and documents by email with authorised contact details; the Assistant Drug Controller will review and issue NOC electronically. Temporary acceptance of signed letterhead for labeling/testing guarantees substitutes for notarised stamp paper. Online signed requests may be made for pending Direct Delivery shipments. Vaccines and certain critical IVDs sampled fully may be released after document and protocol review, bank risk certificate and prior track record subject to central regulator conditions. Testing waivers for medicines used by treating physicians for COVID-19 may be allowed based on previous testing history.</description>
      <category>Circulars</category>
      <law>Customs</law>
      <pubDate>Tue, 14 Apr 2020 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/circulars?id=63879</guid>
    </item>
  </channel>
</rss>